QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference

Rhea-AI Summary

QuidelOrtho (Nasdaq: QDEL), a leader in in vitro diagnostic technologies, announced its management team's participation in the 44th Annual William Blair Growth Stock Conference. The event is scheduled for June 5, 2024, in Chicago, IL. The company's presentation will take place at 1:20 p.m. CT. Interested parties can access the live webcast and replay on QuidelOrtho's Investor Relations page.

Positive

• QuidelOrtho's participation in the prestigious William Blair Growth Stock Conference can enhance visibility and investor interest.
• The live webcast and replay availability provide broader access for potential investors and stakeholders.

Negative

• The announcement lacks specific financial or clinical data, offering information on the company's current performance.
• No new product releases, innovations, or partnerships were disclosed in this update, leaving important growth metrics unaddressed.

SAN DIEGO--(BUSINESS WIRE)-- QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced that members of its management team are scheduled to participate in the 44^th Annual William Blair Growth Stock Conference on June 5, 2024, in Chicago, IL.

The Company will host a presentation at 1:20 p.m. CT. Interested parties can access the live webcast and replay in the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com/.

About QuidelOrtho Corporation

QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.

Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.

QuidelOrtho is advancing diagnostics to power a healthier future.

For more information, please visit www.quidelortho.com.

Source: QuidelOrtho Corporation

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523812581/en/

Investor Contact:

Juliet Cunningham

Vice President, Investor Relations

IR@QuidelOrtho.com

Media Contact:

D. Nikki Wheeler

Senior Director, Corporate Communications

media@quidelortho.com

Source: QuidelOrtho Corporation

FAQ

What event is QuidelOrtho participating in on June 5, 2024?

QuidelOrtho is participating in the 44th Annual William Blair Growth Stock Conference.

What time is QuidelOrtho's presentation at the William Blair Growth Stock Conference?

QuidelOrtho's presentation is scheduled for 1:20 p.m. CT.

How can I access the live webcast of QuidelOrtho's presentation at the William Blair Growth Stock Conference?

The live webcast can be accessed through the 'Events & Presentations' section of QuidelOrtho's Investor Relations page.

Where can I find the replay of QuidelOrtho's presentation at the William Blair Growth Stock Conference?

The replay will be available on QuidelOrtho's Investor Relations page.